Iterum Therapeutics
ITRM
ITRM
21 hedge funds and large institutions have $42.3M invested in Iterum Therapeutics in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$129K | |
| 2 | +$65.3K | |
| 3 | +$55.5K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$20.5K |
| 5 |
Morgan Stanley
New York
|
+$11.1K |
Top Sellers
| 1 | -$1.06M | |
| 2 | -$810K | |
| 3 | -$406K | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$202K |
| 5 |
Franklin Resources
San Mateo,
California
|
-$182K |